Ozone-loaded oil droplets trigger senescence and immune cell death in cancer cells
In this abstract, ozone delivered by saponin-emulsified nano/micro oil droplets caused intracellular glycation, senescence and immunogenic cell death, with suppressed tumor growth in vivo. [1]
Automatic summary · not editorially reviewed
The key findings
Saponin-emulsified nano/micro oil droplets were engineered to deliver ozone into cells. [1]
Delivered ozone promoted intracellular glycation and accumulation of advanced glycation end-products, reported to induce senescence. [1]
In vivo, the abstract reports suppressed tumor growth and strong immune cell infiltration as evidence of immunogenic cell death. [1]
The source at a glance
- Study type / format
- Preclinical laboratory study (abstract)
- Population / context
- Cancer cells and tumor tissue in laboratory experiments described in the abstract
- Summary based on
- Study abstract
- Original publication
- October 7, 2026
Ozone delivery platform tested in cancer cells
The authors built a saponin-emulsified nano/micro-sized oil droplet system to carry ozone. After cells take the droplets up, they localize to lysosomes; the saponin surfactant promotes lysosomal membrane permeabilization, releasing the droplets into the cytoplasm. The delivered ozone then triggers intracellular oxidative stress and reactive oxygen species. This describes a laboratory delivery approach, not a treatment tested for human benefit.
Supporting source [1]
Glycation, senescence and immunogenic cell death observed
The abstract reports that ozone delivery promotes intracellular glycation reactions, leading to accumulation of advanced glycation end-products (AGEs). This is said to induce cellular senescence and reduce nuclear proliferative activity. These disruptive processes are reported to elicit immunogenic cell death, shown by suppressed tumor growth and strong immune cell infiltration in tumor tissue in vivo. These are reported associations in this experimental setting, not proof of cause in humans.
Supporting source [1]
Abstract-only scope of the ozone droplet findings
This explainer is based only on the abstract; the full text was not reviewed. The abstract does not report sample sizes, follow-up duration, tumor models, comparator groups or statistical uncertainty. It also gives no data on safety, dosing or effects in people. The findings should therefore be read as early preclinical results from a delivery platform, not as evidence of a cancer therapy ready for patients.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. Sample sizes, tumor models, comparators, follow-up and statistical uncertainty are not reported, and no human safety or dosing data are given.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Lu J, Zheng R, Yu J, Guo Z, Chen S, Li Y, Ying Y, Li J, Qiao L, Zheng J, Wei Y, Xu B, Zhao L, Che S. · europepmc.org · October 7, 2026